Krizanac S - Search Results

1

Natural zeolite clinoptilolite: new adjuvant in anticancer therapy.

Pavelić K, Hadzija M, Bedrica L, Pavelić J, Dikić I, Katić M, Kralj M, Bosnar MH, Kapitanović S, Poljak-Blazi M, Krizanac S, Stojković R, Jurin M, Subotić B, Colić M. Pavelić K, et al. Among authors: krizanac s. J Mol Med (Berl). 2001;78(12):708-20. doi: 10.1007/s001090000176. J Mol Med (Berl). 2001. PMID: 11434724 Clinical Trial.

2

Squamous cell lung carcinomas: the role of nm23-H1 gene.

Bosnar MH, Pavelić K, Krizanac S, Slobodnjak Z, Pavelić J. Bosnar MH, et al. Among authors: krizanac s. J Mol Med (Berl). 1997 Aug;75(8):609-13. doi: 10.1007/s001090050146. J Mol Med (Berl). 1997. PMID: 9297629

3

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Pavelić K, Krizanac S, Cacev T, Hadzija MP, Radosević S, Crnić I, Levanat S, Kapitanović S. Pavelić K, et al. Among authors: krizanac s. Mol Med. 2001 Jul;7(7):442-53. Mol Med. 2001. PMID: 11683369 Free PMC article.

4

Insulin-like growth factor family and combined antisense approach in therapy of lung carcinoma.

Pavelić J, Pavelić L, Karadza J, Krizanac S, Unesić J, Spaventi S, Pavelić K. Pavelić J, et al. Among authors: krizanac s. Mol Med. 2002 Mar;8(3):149-57. Mol Med. 2002. PMID: 12142546 Free PMC article.

5

The consequences of insulin-like growth factors/receptors dysfunction in lung cancer.

Pavelic J, Krizanac S, Kapitanovic S, Pavelic L, Samarzija M, Pavicic F, Spaventi S, Jakopovic M, Herceg-Ivanovi Z, Pavelic K. Pavelic J, et al. Among authors: krizanac s. Am J Respir Cell Mol Biol. 2005 Jan;32(1):65-71. doi: 10.1165/rcmb.2004-0232OC. Epub 2004 Oct 28. Am J Respir Cell Mol Biol. 2005. PMID: 15514114

6

Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.

Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, Husnjak K, Unusic J, Pavelic K. Sirotkovic-Skerlev M, et al. Among authors: krizanac s. Exp Mol Pathol. 2005 Aug;79(1):42-50. doi: 10.1016/j.yexmp.2005.02.004. Epub 2005 Apr 7. Exp Mol Pathol. 2005. PMID: 16005711

7

Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas.

Bosnar MH, Pavelić K, Hrasćan R, Zeljko Z, Krhen I, Marekoyic Z, Krizanac S, Pavelíc J. Bosnar MH, et al. Among authors: krizanac s. J Cancer Res Clin Oncol. 1997;123(9):485-8. doi: 10.1007/BF01192202. J Cancer Res Clin Oncol. 1997. PMID: 9341897

8

Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.

Pavelić K, Dedivitis RA, Kapitanović S, Cacev T, Guirado CR, Danić D, Radosević S, Brkić K, Pegan B, Krizanac S, Kusić Z, Spaventi S, Bura M. Pavelić K, et al. Among authors: krizanac s. Mutat Res. 2006 Jul 25;599(1-2):45-57. doi: 10.1016/j.mrfmmm.2006.01.021. Epub 2006 May 15. Mutat Res. 2006. PMID: 16698048 Free article.

9

TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions.

Sirotkovic-Skerlev M, Cacev T, Krizanac S, Kulić A, Pavelic K, Kapitanovic S. Sirotkovic-Skerlev M, et al. Among authors: krizanac s. Exp Mol Pathol. 2007 Aug;83(1):54-8. doi: 10.1016/j.yexmp.2006.11.004. Epub 2007 Jan 17. Exp Mol Pathol. 2007. PMID: 17234183 Free article.

10

Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.

Cacev T, Radosević S, Krizanac S, Kapitanović S. Cacev T, et al. Among authors: krizanac s. Carcinogenesis. 2008 Aug;29(8):1572-80. doi: 10.1093/carcin/bgn164. Epub 2008 Jul 14. Carcinogenesis. 2008. PMID: 18628251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters